NCT00643500View on ClinicalTrials.gov

Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy

PHASE4CompletedINTERVENTIONAL
Enrollment

342

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Epilepsy, Partial
Interventions
DRUG

Levetiracetam

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00643500 - Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy | Biotech Hunter | Biotech Hunter